Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Influence of aging on the preB cell product, λ5, and its contribution to age-related bone loss

Award Number: R56AG076730
ORGANIZATION: NATIONAL INSTITUTE ON AGING
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 07/01/2022
PERIOD OF PERFORMANCE END DATE: 06/30/2025

Group Awards By:

View Award Description

Influence of aging on the preB cell product, λ5, and its contribution to age-related bone loss - Project Summary: Aging is associated with a decrease in bone mass that coincides with decreased numbers of early B cells (proB and preB cells). PreB cells approach the endosteum where bone forming osteoblasts and bone resorbing osteoclasts reside. PreB cells express two genes, IGLL1 and VPREB, whose proteins (λ5 and VpreB) form the surrogate light chain (SLC) that binds immunoglobulin µHC to form the cell-surface expressed preB cell receptor (preBCR). In both mice and humans, early B cell numbers and their λ5-expression decrease with age. Little is known about the role of early B cells and λ5 expression in bone homeostasis and aging. This represents a significant gap in our knowledge. Previously, we observed increased bone fragility of λ5-deficient mice. Since it is recognized that both early B cell numbers and λ5 expression normally decline with age, we reasoned that λ5 might contribute to skeletal aging. Our preliminary data show that absence of λ5 disrupts acquisition of trabecular bone, decreases trabecular bone mass and accelerates bone aging. This phenotype is more prominent in female than male mice, resembling the natural history of osteoporosis in human, and importantly this process can be reversed. Irradiated λ5-/- mice reconstituted with wild type (WT) bone marrow show recovery of trabecular bone mass, whereas loss of trabecular bone mass was observed when WT mice received λ5-/- marrow. We have identified a subset of mesenchymal stromal/stem cells (MSCs) that express λ5 protein. Similar to the aging- associated decrease in early B cell numbers, the numbers of λ5-expressing MSCs decrease with age. Our preliminary studies show that disrupting λ5, or its known ligands (heparan sulfate and galectins) in bone marrow MSC cultures, diminishes osteoblast development and function. Moreover, loss of λ5 in MSCs promotes their development into adipocytes at the expanse of osteoblasts, resulting in an MSC aging phenotype which induces increased adiposity. This suggests a role for λ5 in MSC developmental fate decision. Building on our novel findings, we will test the hypothesis that aging induces changes in λ5 expression in MSCs and early B cells that impact osteoblast development and function and lead to age-associated bone loss. Our premise is that studies using λ5-deficient (λ5-/-) and B cell-depleted (JH-/-) mice will elucidate mechanisms of λ5 control of bone homeostasis and skeletal aging. In specific Aim 1, we will determine how changes in λ5 expression affect skeletal aging. In aim 2, we will identify contributions of major cellular source(s) of λ5 to bone development and aging. In aim 3, we will determine the mechanisms by which λ5 controls bone homeostasis and aging. Our experimental approach incorporates the use of primary MSCs and early B cell co-culture, Mass Spec of early B cell secreted factors affecting MSCs, and adoptive transfer and conditional deletion to dissect the in-vivo role of λ5 during aging. The significance of this project is that successful pursuit of these aims will advance the field of osteoimmunology through identifying λ5 as a new therapeutic target for prevention and/or treatment of age- associated bone loss.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = -$18 )
2026	2022	UNIVERSITY OF ALABAMA AT BIRMINGHAM	701 S 20TH STREET	BIRMINGHAM	AL	35294	JEFFERSON	USA	Aging Research	000	1	1/26/2026	NEW	-$18
														Subtotal = -$18

Issue Date FY: 2024 ( Subtotal = $0 )
2024	2022	UNIVERSITY OF ALABAMA AT BIRMINGHAM	701 S 20TH STREET	BIRMINGHAM	AL	35294	JEFFERSON	USA	Aging Research	000	1	7/10/2024	NEW	$0
														Subtotal = $0

Issue Date FY: 2022 ( Subtotal = $304,425 )
2022	2022	UNIVERSITY OF ALABAMA AT BIRMINGHAM	701 S 20TH ST	BIRMINGHAM	AL	35294	JEFFERSON	USA	Aging Research	000	1	6/17/2022	NEW	$304,425
														Subtotal = $304,425

Grand Total All Awards = $304,407

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Influence of aging on the preB cell product, λ5, and its contribution to age-related bone loss

Award Number: R56AG076730

ORGANIZATION: NATIONAL INSTITUTE ON AGING

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 07/01/2022

PERIOD OF PERFORMANCE END DATE: 06/30/2025

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer